Long-awaited oral antiviral pills to combat mild to moderate COVID-19 at home could be available in Tennessee as soon as next week, according to the state’s top health official.
Dr. Lisa Piercey, commissioner of the Tennessee Department of Health, said during a news briefing Monday that the U.S. Food and Drug Administration is expected this week to authorize a new treatment called molnupiravir from the drug company Merck, which reduces the risk of COVID-19 hospitalization and death by around 30% if taken within the first five days of illness.
In the coming weeks, the FDA is expected to review a similar pill from Pfizer called Paxlovid that, according to the drug company, reduces COVID-19 hospitalization and death by nearly 90% if taken within three days. Paxlovid likely won’t be available in Tennessee until January, Piercey said.
The drugs are for adults at high risk for serious infections, such as those with obesity, heart disease and lung disease.
Piercey compared them to Tamiflu, a well-known pill that’s commonly prescribed to treat influenza in outpatient settings.
